American Journal of Rhinology & Allergy

Scope & Guideline

Fostering collaboration in the pursuit of respiratory wellness.

Introduction

Welcome to your portal for understanding American Journal of Rhinology & Allergy, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1945-8924
PublisherSAGE PUBLICATIONS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2009 to 2024
AbbreviationAM J RHINOL ALLERGY / Am. J. Rhinol. Allergy
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2455 TELLER RD, THOUSAND OAKS, CA 91320

Aims and Scopes

The American Journal of Rhinology & Allergy focuses on advancing the understanding and treatment of rhinologic and allergic conditions through rigorous research and clinical studies. Its scope encompasses a wide array of topics within rhinology, particularly addressing chronic rhinosinusitis, allergic rhinitis, and their associated disorders.
  1. Chronic Rhinosinusitis Research:
    This includes studies on the pathophysiology, treatment outcomes, and management strategies for chronic rhinosinusitis, with a particular emphasis on nasal polyps and eosinophilic chronic rhinosinusitis.
  2. Allergic Rhinitis and Immune Response:
    Research in this area focuses on the mechanisms of allergic responses, the efficacy of immunotherapy, and the impact of various treatment modalities on allergic rhinitis.
  3. Surgical Techniques and Innovations:
    The journal publishes articles on new surgical techniques, outcomes of various rhinologic procedures, and advancements in endoscopic surgery for sinonasal conditions.
  4. Olfactory Dysfunction Studies:
    Investigations into the causes, prevalence, and treatment of olfactory dysfunction, particularly in the context of chronic rhinosinusitis and post-viral syndromes.
  5. Biologics and Pharmacotherapy:
    Research on the use of biologic therapies for treating chronic rhinosinusitis and allergic conditions, including their efficacy, safety, and mechanisms of action.
  6. Patient-Centered Outcomes:
    The journal emphasizes studies assessing quality of life, patient-reported outcomes, and the psychosocial implications of rhinologic diseases.
The American Journal of Rhinology & Allergy has evolved to reflect emerging trends and topics of increasing relevance in rhinology and allergy research. These themes showcase the journal's responsiveness to new scientific developments and clinical needs, indicating the direction of future research efforts.
  1. Biologics and Targeted Therapies:
    There is a growing body of literature on the efficacy and safety of biologic agents like Dupilumab and Mepolizumab in managing chronic rhinosinusitis and allergic conditions, reflecting a shift towards personalized medicine.
  2. AI and Machine Learning Applications:
    Emerging studies are exploring the role of artificial intelligence and machine learning in diagnosis, treatment planning, and patient education within rhinology, indicating a technological advancement in the field.
  3. Longitudinal Outcomes Studies:
    Research focusing on long-term outcomes of surgical and medical interventions for chronic rhinosinusitis and allergic rhinitis is gaining traction, emphasizing the importance of sustained patient-centered care.
  4. Impact of Environmental Factors on Rhinologic Conditions:
    An increasing number of studies are examining how environmental factors, such as air pollution and climate change, affect the prevalence and severity of allergic and sinonasal diseases.
  5. Psychosocial and Quality of Life Research:
    There is a notable increase in studies assessing the psychosocial impact and quality of life outcomes for patients with rhinologic conditions, highlighting the importance of holistic patient care.

Declining or Waning

While the American Journal of Rhinology & Allergy continues to thrive in many research areas, certain topics have shown a decline in frequency and relevance within recent publications. This waning interest may reflect shifting priorities in research or advancements in understanding that reduce the need for ongoing exploration in these areas.
  1. Traditional Antibiotic Use in Sinusitis:
    Research on traditional antibiotic treatment patterns for sinusitis has decreased, possibly due to increasing awareness of antibiotic resistance and a shift toward more evidence-based approaches.
  2. Non-Surgical Management of Chronic Rhinosinusitis:
    There has been a noticeable reduction in studies focusing on non-surgical management strategies for chronic rhinosinusitis, as the field increasingly emphasizes surgical interventions and biologic therapies.
  3. Basic Science Studies on Sinonasal Anatomy:
    Research centered solely on anatomical studies of the sinonasal complex has diminished, likely due to the growing focus on translational research that connects clinical outcomes with anatomical insights.
  4. General Public Health Studies:
    The journal has seen fewer publications on broader public health implications of rhinologic conditions, as the focus has shifted toward more specific clinical and therapeutic studies.
  5. Epidemiological Studies of Allergic Conditions:
    There is a decline in epidemiological research specifically targeting allergic conditions, possibly due to a saturation of existing data and a shift toward more mechanistic studies.

Similar Journals

ALLERGY

Exploring Breakthroughs in Allergic Disease Understanding.
Publisher: WILEYISSN: 0105-4538Frequency: 12 issues/year

ALLERGY is a leading international journal published by WILEY, dedicated to advancing the understanding of allergic diseases and immunology. With an ISSN of 0105-4538 and an E-ISSN of 1398-9995, this esteemed journal has been at the forefront of the field since its inception in 1948 and continues to publish high-quality research up until 2024. Positioned in the Q1 category for both Immunology and Allergy, ALLERGY ranks impressively within the top percentiles of its categories, underscoring its significant impact, as reflected in its Scopus rankings (#11 out of 233 in Immunology and Allergy, and #14 out of 236 in Immunology and Microbiology). Researchers and practitioners accessing this journal can expect a rigorous selection of peer-reviewed articles that address current challenges, innovative therapies, and advancements in the immunological sciences. Although it is not an open-access journal, ALLERGY remains vital for academics, healthcare professionals, and students alike, fostering a deeper understanding of the mechanisms and treatments associated with allergies.

Alergologia Polska-Polish Journal of Allergology

Exploring the frontiers of allergic disease management.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 2353-3854Frequency: 4 issues/year

Alergologia Polska - Polish Journal of Allergology, published by TERMEDIA PUBLISHING HOUSE LTD, is a distinguished academic journal dedicated to advancing the field of allergy research and treatment. With the ISSN 2353-3854, this journal serves as an essential resource for professionals, researchers, and students alike, offering a platform for the dissemination of novel findings and comprehensive reviews in allergic diseases. The journal emphasizes open access to ensure widespread availability and engagement within the scientific community. Alergologia Polska aims to enhance the understanding of allergy mechanisms, diagnostics, and management strategies, fostering collaboration and innovation among experts in the field. Set against the vibrant backdrop of Poznań, Poland, this publication not only highlights clinical and experimental research but also promotes interdisciplinary discussions that are pivotal for tackling complex allergic conditions globally.

Therapeutic Advances in Allergy and Rhinology

Empowering researchers and clinicians in allergy and rhinology.
Publisher: SAGE PUBLICATIONS INCISSN: 2753-4030Frequency: 1 issue/year

Therapeutic Advances in Allergy and Rhinology, published by SAGE Publications Inc, is an esteemed journal that focuses on advancing the fields of allergy and rhinology through innovative and impactful research. As an Open Access journal, it provides a platform for researchers, clinicians, and students to share significant findings and therapeutic developments aimed at improving patient outcomes related to allergic conditions and nasal disorders. The journal aims to publish high-quality peer-reviewed articles, reviews, and case studies that contribute to a deeper understanding of the pathophysiology and management of allergies and rhinological conditions. By fostering collaborative dialogue across various disciplines, Therapeutic Advances in Allergy and Rhinology plays a crucial role in enhancing clinical practice and guiding future research in this vital area of health. With an ISSN of 2753-4030, the journal continues to establish itself as a key resource for anyone involved in allergy and rhinology research and practice.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Championing Excellence in Allergy and Immunopathology Scholarship
Publisher: CODON PUBLICATIONSISSN: 0301-0546Frequency: 6 issues/year

ALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.

International Forum of Allergy & Rhinology

Shaping the Future of Allergy and Rhinology
Publisher: WILEYISSN: 2042-6976Frequency: 12 issues/year

The International Forum of Allergy & Rhinology, published by Wiley, is a leading journal dedicated to advancing the field of allergy, rhinology, and related health issues. With an ISSN of 2042-6976 and an E-ISSN of 2042-6984, this esteemed journal showcases high-quality research and innovative findings by publishing original articles, reviews, and clinical case studies. As of 2023, it holds impressive rankings within the Scopus metrics, placing it in the top 2% for Medicine in Otorhinolaryngology and in the top 16% for Immunology and Allergy, highlighting its influence and credibility in these specialized fields. Operating without an open access model, the journal aims to offer comprehensive insights into the diagnosis and treatment of allergic conditions and their impact on rhinology, fostering a deeper understanding among researchers and practitioners. Located in Hoboken, NJ, the journal has been at the forefront of scientific exploration since its inception in 2011, continuing to play a pivotal role in informing the academic community and influencing clinical practice up to 2024 and beyond.

Current Opinion in Allergy and Clinical Immunology

Advancing knowledge for better patient outcomes in immunology.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1528-4050Frequency: 6 issues/year

Current Opinion in Allergy and Clinical Immunology, published by Lippincott Williams & Wilkins, is a pivotal journal that serves as a key resource for professionals in the fields of immunology and allergy. With an ISSN of 1528-4050 and an E-ISSN of 1473-6322, this journal presents cutting-edge reviews of the latest research findings, methodologies, and therapeutic approaches in the management of allergic and immunological disorders. With a Q3 category ranking in both Immunology and Allergy for 2023, and a Scopus rank of #103 in Immunology and Allergy, it reflects a solid position within the scientific community. Operating in the highly dynamic fields of immunology and clinical practice since its inception in 2001, the journal aims to harmonize emerging research trends with clinical applications to enhance patient outcomes. Although it does not currently offer Open Access options, the journal's substantial impact factor attests to its significance as a scholarly resource. By disseminating high-quality reviews and expert opinions, Current Opinion in Allergy and Clinical Immunology continues to foster knowledge advancement and professional development among researchers, practitioners, and students alike.

ALLERGY AND ASTHMA PROCEEDINGS

Advancing knowledge in Allergy and Asthma research.
Publisher: OCEAN SIDE PUBLICATIONS INCISSN: 1088-5412Frequency: 6 issues/year

ALLERGY AND ASTHMA PROCEEDINGS, published by Ocean Side Publications Inc, is a vital resource in the fields of Immunology, Allergy, and Pulmonary Medicine. With an impressive trajectory of publication from 1996 to 2024, this journal serves as a platform for cutting-edge research and advancements in the understanding of allergic and asthmatic conditions. Positioned in the Q3 quartile for Immunology and Allergy and Q2 for both Medicine (miscellaneous) and Pulmonary Medicine, the journal exhibits a robust impact within the academic community, boasting Scopus rankings that reflect its significance. The journal offers open access options, allowing for the dissemination of critical findings to a wider audience. Aimed at researchers, healthcare professionals, and students alike, ALLERGY AND ASTHMA PROCEEDINGS addresses the complexities of respiratory diseases and facilitates the sharing of knowledge that is essential to improving patient care and outcomes.

Asia Pacific Allergy

Transforming Allergy Care Through Collaborative Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2233-8276Frequency: 4 issues/year

Asia Pacific Allergy, published by Lippincott Williams & Wilkins, is a prominent academic journal dedicated to advancing research and clinical practice in the fields of dermatology, immunology, and allergy. With its ISSN 2233-8276 and E-ISSN 2233-8268, the journal provides a platform for innovative studies and reviews that cater to an international audience of researchers, healthcare professionals, and students involved in allergy and related disorders. Although it does not currently offer open access to its publications, the journal's robust output from 2015 to 2017 and its ongoing contribution to the literature from 2021 to 2024 showcase the evolving landscape of allergy research in the Asia Pacific region. Recognized in the 2023 Journal Citation Reports, it holds a Q2 ranking in Dermatology and a Q3 ranking in Immunology and Allergy, while its Scopus ranks further emphasize its significance within these domains, positioning it among the top journals in the field. As a source of cutting-edge research, Asia Pacific Allergy plays a vital role in fostering collaboration and knowledge dissemination, ultimately assisting in the betterment of patient care and treatment strategies across the region.

RHINOLOGY

Leading the way in sinus health advancements.
Publisher: INT RHINOLOGIC SOCISSN: 0300-0729Frequency: 6 issues/year

RHINOLOGY is a premier journal dedicated to the field of otorhinolaryngology, published by the International Rhinologic Society. With a notable impact factor reflecting its standing in the academic community, RHINOLOGY ranks in the Q1 quartile for both Medicine (miscellaneous) and Otorhinolaryngology, placing it among the top-tier journals in the field. Since its inception in 1973, this biannual publication has served as a vital resource for researchers, clinicians, and students, covering a broad range of topics related to nasal and sinus disorders, their pathophysiology, diagnosis, and treatment. The journal's commitment to disseminating high-quality research ensures that it remains at the forefront of advancements in rhinology, making it an essential platform for those seeking to contribute to and stay informed about critical developments in this ever-evolving discipline. The journal operates under a traditional subscription model, providing access to its valuable content primarily through academic libraries and institutions.

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY

Fostering excellence in the diagnosis and treatment of pediatric conditions.
Publisher: ELSEVIER IRELAND LTDISSN: 0165-5876Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, published by Elsevier Ireland Ltd, stands as a pivotal resource in the fields of pediatric otorhinolaryngology, pediatrics, and related medical disciplines. With a historical publication record spanning from 1979 to 2024, this journal is dedicated to advancing research and clinical practice in the diagnosis and treatment of ear, nose, and throat disorders in children. As evidenced by its 2023 rankings, the journal maintains a commendable position within the Q2 category of its field, reflecting its impact and the quality of research it disseminates, ranking #43 out of 123 in Otorhinolaryngology and #131 out of 330 in Pediatrics. Researchers, clinicians, and students alike can benefit from a wealth of studies and reviews designed to inform and enhance pediatric care. Although the journal does not currently offer open access, it remains an indispensable tool for those seeking to stay at the forefront of pediatric health and otolaryngological innovations.